BridgeBio Pharma: Q4 Earnings Snapshot

PALO ALTO, Calif. (AP) _ BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $147.2 million in its fourth quarter.

The Palo Alto, California-based company said it had a loss of $1.01 per share.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 83 cents per share.

The rare disease drug developer posted revenue of $12.9 million in the period, also falling short of Street forecasts. Five analysts surveyed by Zacks expected $33.2 million.

For the year, the company reported that its loss widened to $562.5 million, or $3.90 per share. Revenue was reported as $69.7 million.

BridgeBio Pharma shares have dropped 56% since the beginning of the year. The stock has fallen 89% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BBIO at https://www.zacks.com/ap/BBIO